Category Archives: Nanotechnology

Global "Nanotechnology in Medical Devices Market" research report has all the necessary vital details asked by the clients or any audiences in terms of market advantages or disadvantages and future market scope all mentioned in a very crystal clear manner. The report eloquently mentioned all the information regarding market competitors, growth rate, revenue ups and downs, regional players, industrial players, and applications. Even the most measly information depicting market figures are comprehensively analyzed and before being presented to the clients. The industrial players Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), Smith & Nephew plc (U.K.)., Dentsply International, Mitsui Chemicals, Inc., AAP Implantate AG are all provided so as to make it easier for the audiences to understand the market growth rate. The current Nanotechnology in Medical Devices market research report has demonstrated all the vital market growth factors and economic fluctuations mentioned owing to the immense attention gained in recent years.

Click HereTo Access The Sample Report::

Global Market portal aims to provide reports like these in order to draw the attention of many of the clients wanting to extrapolate some of the vital details of the Nanotechnology in Medical Devices market on a global scale. The Nanotechnology in Medical Devices market dossier talks about the market segmentation created on the basis of consensus made, product type, government norms, key industrial players, competitive landscapes, applications, end-user, topological players, and more. The report presents a demand for individual segment in each region. It demonstrates various segments Active Implantable Medical Devices, Biochip, Portable Material and sub-segments Treatment Using, Diagnostic Using, Research Using of the global Nanotechnology in Medical Devices market. The current report data simulates the market status and investment gains or losses in a very illustrative manner so as to provide the analyzed data in a very refreshed format.

Read Detailed Index Of Full Research Study @:: http://www.reportsbuzz.com/53388/global-nanotechnology-in-medical-devices-market-outlook-2018/

Though the paper may have certain limitations in terms of providing the information, the record has purported all the deep-seated intricate information. The clients and other readers can have all the global Nanotechnology in Medical Devices market highlights provided in this very report. The geographical regions also play an important role in enhancing the growth and development of the global Nanotechnology in Medical Devices market. The report has all the vital information regarding supply and demand, market development enhancers, market share, sales distributors, and more advocated in a very formal pattern.

There are 15 Chapters to display the Global Nanotechnology in Medical Devices market

Chapter 1, Definition, Specifications and Classification of Nanotechnology in Medical Devices , Applications of Nanotechnology in Medical Devices , Market Segment by Regions;Chapter 2, Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;Chapter 3, Technical Data and Manufacturing Plants Analysis of Nanotechnology in Medical Devices , Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);Chapter 5 and 6, Regional Market Analysis that includes United States, China, Europe, Japan, Korea & Taiwan, Nanotechnology in Medical Devices Segment Market Analysis (by Type);Chapter 7 and 8, The Nanotechnology in Medical Devices Segment Market Analysis (by Application) Major Manufacturers Analysis of Nanotechnology in Medical Devices ;Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Active Implantable Medical Devices, Biochip, Portable Material, Market Trend by Application Treatment Using, Diagnostic Using, Research Using;Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;Chapter 11, The Consumers Analysis of Global Nanotechnology in Medical Devices ;Chapter 12, Nanotechnology in Medical Devices Research Findings and Conclusion, Appendix, methodology and data source;Chapter 13, 14 and 15, Nanotechnology in Medical Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Enquire Here Get customization & check discount for report @: http://www.reportsbuzz.com/inquiry-for-buying.html?repid=53388

Originally posted here:
Global Nanotechnology in Medical Devices Market Is Set for a Rapid Growth and is Expected to Reach USD Billion by 2027: Stryker Corporation , 3M...

The Indian Institute of Technology Guwahati (IITG) along with RR Animal Healthcare Ltd. has jointly developed affordable Covid-19 related diagnostic kits and already supplied to Assam health department.

A statement issued by IITG said it became the first institute in the country to demonstrate an efficient model to develop import-substitute Covid-19 kits from lab-scale to prototype level, field/hospital testing and commercialising thereby saving valuable foreign exchange for the country, timely delivery and customising as per the needs of the user.

"These kits, being developed presently at the Center of Nanotechnology, IIT Guwahati, are now supplied regularly in large quantities to the National Health Mission, Assam and several hospitals across the country," it said.

For latest updates on coronavirus outbreak, click here

Initially, these included the ICMR approved SPILD Viral Transport Media (VTM) Kits. Over the past several months, with the lockdown being implemented across the country and with very less air connectivity, acquiring large quantities of Covid-19 kits became very difficult.

To overcome this crisis, the National Health Mission, Assam had approached Prof. T. G. Sitharam, director, IIT Guwahati, with a request to develop VVTM kits, RNA extraction kits and RT-PCR kits and help the state government in their efforts to overcome this shortage.

IIT Guwahati immediately took up this challenge and strategised to develop these kits in-house to meet the growing requirement of these kits during this time of Covid-19 pandemic, said the statement.

The IITG said more than 2.5 Lakhs VTM kits have already been supplied to NHM, Assam. Several testing laboratories across the country have also started procuring these import substitute kits due to their high quality, affordable price and timely delivery schedules.

"The performance of the indigenously developed RNA extraction kits have also been highly satisfactory as per the Guwahati Medical College and Hospital and the institute has started supplying these RNA extraction kits in large quantities to the state government. Similarly, the indigenously developed RT-PCR kits are being validated presently and the production, as well as supply of these kits is likely to commence soon," it said.

These affordable and sterile SPILD Viral VTM kits, RT-PCR kits and RNA isolation kits have been developed at the Center for Nanotechnology, IIT Guwahati, jointly with RR Animal Healthcare Ltd. with inputs from GMCH by the research teams led by Prof. Parameswar Krishnan Iyer, Prof. Siddhartha Sankar Ghosh from IIT Guwahati and Dr Labanyamoy Kole and Dr Debashish Dutta of RR Animal Healthcare.

See the article here:
IIT Guwahati becomes the first institute to produce Covid-19 diagnostic kits - Deccan Herald

DUBLIN, Aug. 10, 2020 /PRNewswire/ -- The "Global Tactical and Outdoor Clothing Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The tactical and outdoor clothing market is forecast to show significant growth during the period 2020-2024. This research analyzes the current global market scenario, latest drivers and restraints to provide current market analysis as well as expected market situation in future.

The geographic regions covered in the global tactical and outdoor clothing market includes: North America, South America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA)

Evolution of protective and nanotechnology clothing is recognized as one of the key driving factor for tactical and outdoor clothing market growth over the forecast period.

Smart technologies in tactical and outdoor clothing, and emergence of flame-resistant tactical clothing, will be some of the other factors impacting the market growth.

To strengthen their market position, many vendors are increasing investment. The investments are targeted to increase capacity or improve distribution network and logistics & warehousing. Based on detailed study of the market, vendors product offering and their geographical presence. Decathlon, Luxottica Group (Oakley), Propper, and Under Armour were identified as some of the prominent players in this market.

The 2020-2024 report on global tactical and outdoor clothing market provides:

Key Topics Covered:

1 Executive Summary

2 Market Landscape2.1 Market Ecosystem2.2 Market Characteristics2.3 Value Chain Analysis

3 Market Sizing3.1 Market Definition3.2 Market Segmentation Analysis3.3 Market Size 20193.4 Market Outlook: Forecast 2019-2024

4 Five Forces Analysis4.1 Bargaining Power of Buyers4.2 Bargaining Power of Suppliers4.3 Threat of New Entrants4.4 Threat of Substitutes4.5 Threat of Rivalry4.6 Market Condition

5 Market Segmentation

6 Customer Landscape

7 Geographic Landscape7.1 Geographic Segmentation7.2 Geographic Comparison7.3 Europe - Market Size and Forecast 2019-20247.4 North America - Market Size and Forecast 2019-20247.5 APAC - Market Size and Forecast 2019-20247.6 South America - Market Size and Forecast 2019-20247.7 MEA - Market Size and Forecast 2019-20247.8 Key Leading Countries7.9 Market Opportunity

8 Drivers, Challenges and Trends8.1 Market Drivers8.2 Market Challenges8.3 Market Trends

9 Vendor landscape9.1 Overview9.2 Landscape Disruption

10 Vendor Analysis10.1 Vendors Covered10.2 Market Positioning of Vendors

11 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/6ie97w

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Original post:
Global Tactical and Outdoor Clothing Market 2020-2024: Smart Technologies and Flame-Resistant Tactical Clothing Key Growth Factors - PRNewswire

New Delhi: Indian Institute of Technology (IIT) Delhi and Odisha University of Agriculture and Technology (OUAT), Bhubaneswar have signed a Memorandum of Understanding (MoU) to generate frontier technologies and produce quality human resources in the field of agricultural research and education for addressing the challenges faced by the rural communities and improving their quality of life.

OUAT, Bhubaneswar and IIT Delhi would work jointly in the field of Sensor Application in Agriculture, Precision Farming, Geospatial Technology, Nanotechnology, Biotechnology, and related aspects of agriculture, leading to the creation of rural livelihood opportunities.There will be a strengthening of faculty/ scientists through exchange programmes and the use of laboratories of both the organisations.

The MoU was signed by Prof. V. Ramgopal Rao, Director, IIT Delhi and Dr. Pawan Kumar Agrawal, Vice-Chancellor, OUAT Bhubaneswar.

After signing the MoU, Dr. P.K. Agrawal, Vice-Chancellor, OUAT expressed that this collaboration will create new avenues for interdisciplinary research with the involvement of scientists from OUAT and IIT Delhi.

Speaking of the MoU, Prof. Rao, Director, IIT Delhi said, As part of IIT Delhis resolve to strengthen the rural economy through technology interventions, the institute is closely working with multiple ICAR laboratories on a variety of agricultural problems. Through this collaborative agreement with OUAT, we hope to also initiate multiple funded projects between IIT Delhi and OUAT faculty under IIT Delhis Faculty Interdisciplinary Research Programme (FIRP).

The academic and research collaborations between OUAT and IIT Delhi especially in the areas of sensor based agricultural technologies, nanotechnology and biotechnology applications will develop strategies and modern techniques for meeting current challenges faced by agricultural sectors, said Prof. Sunil Kr. Khare, Dean, R&D, IIT Delhi.

There will also be a joint venture to operate research projects having a common interest in both the institutions.

View post:
IIT Delhi, OUAT Bhubaneswar Sign MoU for Strengthening Research & Education in Cutting Edge Areas of Agriculture and Allied Subjects - India...

NEW YORK, Aug. 10, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical company,today announced licensing the intellectual property rights relating to the development of a medical device that has the potential to allow public health professionals to immediately diagnose COVID-19 infection via breath sample and track through a mobile device from the George Washington University ('GW').

Dr. Mona E. Zaghloul, a professor of Electrical and Computer Engineering at GW School of Engineering and Applied Science, and her former doctoral student Yangyang Zhao,developed the design of the device, based on prior work of other former students, in collaboration with the National Institute of Standards and Technologyto detect and distinguish different species of gas. The device is based on nanotechnology Nanoholes using Plasmonics principles. The surface of the device is covered in a thin sheet of gold that can bind with other molecules, like those of a gas. Once the binding occurs, the wavelength of light bouncing off the surface changes, creating a different color of light. Different gases would cause different shifts in light. The results can be available quickly, and artificial intelligence programs can then classify the molecules that are bound to the surface of the device. The results, including the different classes of the molecules, can then be sent to the cloud by a mobile device, allowing the ability to track the data.

Dr. Jeanne A. Jordan, PhD, a professor in Epidemiology at the GW Milken Institute School of Public Health, was instrumental in recognizing the potential diagnostic capabilities of the technology. As the COVID-19 pandemic spread, she suggested alterations to the device. The researchers believe that the modified apparatus, which is as small as a strand of hair, can be coated with a solution designed to bind specifically to the SARS-CoV-2 virus that causes COVID-19. This design would allow the virus to bind to the surface, thereby allowing for the detection of an optical change that could immediately be sensed by phone cameras when an infected person's specimen is applied.

The research by Dr. Zaghloul and Dr. Jordan was funded by a COVID-19 Technology Maturation Grant from GW's Technology Commercialization Office to accelerate the development of this medical device. The device would allow communities to build trackable real-time databases of infection. People can upload information directly to the cloud.

"These are devices that a public health professional could go out with into the field to administer point-of-care testing, either at a walk-up center or directly in the community," Dr. Jordan said. "They're extremely rapidthe turnaround time to having test results is within minutes, and you do the testing right there instead of having to send your sample to a large commercial laboratory with a massive backlog. That would allow these professionals to say immediately if someone needs to be quarantined, and to get the names of their contacts so they can start contact tracing."

Mr.Robb Knie, Chief Executive Officer of Hoth, stated,"The immediate diagnosis and ongoing tracking of COVID-19 is a critical initiative towards mitigating the ongoing spread of COVID-19. This device which is under development would allow users to conduct widespread testing and provide instantaneous results through the administration of a breath sample and tracking through a mobile device. Securing the rights to this paradigm shifting technology in the fight against the global COVID-19 pandemic is a significant opportunity for Hoth and its shareholders. We look forward to working with the team at GW to accelerate the development of this breakthrough technology."

About Hoth Therapeutics, Inc.Hoth Therapeutics, Inc. isa clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development oftwo different vaccine prospects to prevent or treat COVID-19. To learn more, please visitwww.hoththerapeutics.com.

Forward-Looking StatementCertain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws, including statements regarding the proposed offering, timing and the use of proceeds. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to the Company on the date of this press release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including, without limitation, those set forth in the Company's filings with the Securities and Exchange Commission. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Investor Contact:Email:[emailprotected]www.hoththerapeutics.comPhone: (678) 570-6791 LR Advisors LLC

SOURCE Hoth Therapeutics, Inc.

Home

Read the original post:
Hoth Therapeutics Licenses Intellectual Property to Develop Real-time, Breath-Based COVID-19 Mobile Testing Device - PRNewswire

DUBLIN--(BUSINESS WIRE)--The "Future of Therapy: Technology Advances in Drug-device Combination Products" report has been added to ResearchAndMarkets.com's offering.

Drug device combination products are aimed to provide targeted treatment, enable better drug delivery and improve the efficacy of the device and medicine.

This research service (RS) showcases some of these emerging drug-device combination products including drug eluting stents and drug loaded/coated orthopedic implants under implantable drug-device combination and drug-eluting lens and drug-eluting bandages under non-implantable drug device combinations. The research service discusses the impact of these innovations, patents, technology roadmap and growth opportunities.

Key Topics Covered:

1.0 Executive Summary

2.0 Industry Overview

2.1 Drug-device Combination Products Improving Delivery of Drugs or Therapeutics Efficacy of the Device

2.2 Segmentation of Drug-device Combination Based on Product Type

2.3 Segmentation of Drug-device Combination Based on Application Type

2.4 Growth Opportunity: Drug-device Combinations Improving Performance of Medical Devices

2.5 Growth Opportunity: Drug-device Combination Improves Patients' Acceptance of Medication

3.0 Drug-device Combination Product: Innovation Tracker

3.1 Innovations in Drug-eluting Stents

3.1.1 Drug-eluting Stent to Address the Challenge of in-stent Restenosis

3.1.2 Sirolimus-eluting Coronary Stent with Ultrathin Strut

3.1.3 Zotarolimus-eluting Coronary Stent System

3.1.4 Paclitaxel-eluting Vascular Stent System

3.1.5 Key Companies in Drug-eluting Stent Innovations

3.1.6 The US Leads Patent Activity for Drug-eluting Stents

3.1.7 Key Recent Patents in Drug-eluting Stents to Check

3.2 Innovations in Drug-eluting Contact Lens

3.2.1 Drug-eluting Lens Presenting Growth Opportunities to Replace Ocular Drug Delivery Systems

3.2.2 Drug-eluting Clear Corneal Bandage Lens

3.2.3 Antihistamine-releasing Contact Lens for Ocular Allergy

3.2.4 Digital Printed Drug Layers on Contact Lens for Glaucoma Therapy

3.2.5 Digital-eluting Lens for Treating Corneal Pathologies

3.2.6 Moderate to Low Patent Activity of Drug-eluting Contact Lens with Johnson & Johnson Vision Care Inc., Showing High Activity

3.2.7 Key Recent Drug-eluting Contact Lens Patents to Check

3.3 Innovations in Drug-eluting Bandages

3.3.1 Drug-eluting Wound Care Devices Provide Faster Healing and Eliminate Infections

3.3.2 Chitosan-based Wound Dressing for Hemostatic Effect

3.3.3 Kaolin-based Hemostatic Dressing for Emergency Medical Service

3.3.4 Antimicrobial Impregnated Wound Care Dressings to Avoid Wound Infections

3.3.5 Silver, Iodine, Copper Ions for Antimicrobial Activity in Wound Care Bandages

3.3.6 IP Activity of Drug Releasing Wound Care Bandages/Dressings

3.3.7 Key Recent Drug-eluting Kens Patents to Check

3.4 Drug-eluting Orthopedic Implant

3.4.1 Drug-eluting Orthopedic Implants Offering Better Osteointegration and Protection from Infection

3.4.2 Calcium Scaffold Carrying Antibiotic for Infection Management

3.4.3 Peptide-based Bone Graft for Faster Repair

3.4.4 Doxycycline-eluting Synthetic Bone Substitute

3.4.5 Key Research on Drug-coated Orthopedic Implants

3.4.6 Patent Activity of Drug-loaded Orthopedic Devices Dominated by the US Patents

3.4.7 Key Recent Drug Loaded Bone Scaffold Patents to Check

4.0 Emerging Technology Roadmap and Growth Opportunity

4.1 Emerging Technology Roadmap of Drug-eluting Stents (DES)

4.2 Future of Coronary Stents: Gene Eluting Stents to Overcome Restenosis and Late-stent Thrombosis Challenges

4.3 Drug-eluting Lens Envisions Sensor Technology Convergence into its Product

4.4 Smart Wound Dressing Including Sensor Technology Innovations

4.5 Nanotechnology to Improve the Regenerative Properties of Drug-eluting Bone Scaffold

4.6 Business Growth Opportunities - Patient Centric, Patient Specific, and Cost-effective Imaging Redefining Future of Therapy

4.7 Strategic Imperatives for the Future of the Drug-device Combination Products

5.0 Key Industry Contacts

For more information about this report visit https://www.researchandmarkets.com/r/o6msb5

The rest is here:
2020 Market Study on the Future of Therapy: Technology Advances in Drug-device Combination Products - ResearchAndMarkets.com - Business Wire